Currently, DNGT is being used for patients with symptomatic endometriosis with or without surgery [
21]. This progestin agent is reported to decrease the risk of recurrence by inhibiting the growth of endometriotic tissue [
21,
22]. This mechanism can also theoretically prevent MT [
23], and reported cases of MT are very rare [
24]. However, in our hospital, we had four cases in which ovarian carcinoma was diagnosed during DNGT for OMA. MT in two of the four cases was detected entirely in our hospital, and the probability of MT after starting DNGT was 1.2% (
n = 2 of 172). This probability was similar to the ability of endometriosis to transform into malignancy, which has been reported to be approximately 1% of OMAs in previous studies [
14]. In this study, we extracted the details of the patients’ clinical histories. Because all four patients were over 40 years old and nulliparous, we hypothesized that there were several risk factors, including the patient’s age and parity, for using DNGT. To verify the significant influence of risk factors on MT, a multivariate analysis of six factors extracted before starting DNGT was performed (Table
2). Of the six factors, advanced age, nullipara and increased size and recurrence showed significant increases in the probability of MT. In contrast to a previous study in which the association between spontaneous pregnancy and the disease progression of endometriosis was unclear [
25], these results were roughly consistent with those of past reports [
26,
27]. In particular, 19 patients who had all three factors showed a probability of over 20% for the occurrence of ovarian carcinoma (21.1%,
n = 4 of 19). Because the sample number was very small, the result for this extracted high-risk group might be coincidental. Therefore, a larger sample size will be needed to determine the risk factors for MT. However, in contrast to previous studies, large cyst [
26‐
28] and surgical history [
29] did not show a significantly higher probability of MT. “Bilateral cysts” were also not significant. These multivariate analysis results presented the possibility that the characteristics of the patient have a stronger influence on MT than the characteristics and treatment approach of the OMA itself. Because two cases among the four cases of MT exhibited recurrences of OMA after LC and because the other two cases exhibited cyst size enlargement after starting DNGT, careful observation of the cyst size is important, regardless of the use of surgical treatment. However, similar to previous reports [
11], in our hospital, we could not prevent the two cases of MT (Table
1, case 1 and case 2) by follow-up ultrasound examination at an interval of 6 months.